Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system.
about
Role of rubella virus glycoprotein domains in assembly of virus-like particles.Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocationPathogenesis of human immunodeficiency virus infectionEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionCrystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyAltering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccineRequirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengePseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesVirus maturation by budding.Ebola virus VP40 drives the formation of virus-like filamentous particles along with GPEnhancement of mucosal immunization with virus-like particles of simian immunodeficiency virusRapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.Bimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 GagHuman immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagentsHuman immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor proteinThe role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycleMutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytesEffects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidationA proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.Functional domains of the capsid protein of human immunodeficiency virus type 1Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particlesIncorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-polThe impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virusHuman immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.
P2860
Q24517120-3A9FE1FA-A331-4083-B25C-C918A793D5A2Q24603577-C46C2C3A-6A2D-47F5-AFF0-CD7D7978C1F4Q24634681-5B7496BD-F21C-49DB-80C1-C1868E74AC9DQ24645635-E1EAF03B-C579-4FDA-A062-3F6F299B4EE9Q27485930-D28996EC-522C-4640-8277-6E8FB087D412Q27732646-FE699AB2-55C7-4383-88B3-AD076BC6D6EAQ28482252-C6A04B29-131A-43E6-9A71-ADA068BEB63DQ30452154-3FB9CBD2-F5BE-4E3B-B67C-EBDF3364AAAEQ33621078-F17EAFE3-BFD5-42FC-A69C-A0F96BCA554EQ33755041-6193DF1A-517A-468C-A0DA-49307E8B450CQ33782263-674FBA25-00D2-4377-B976-64E2BC491BBCQ33782770-570AB9A5-AFCC-4E2B-B786-D71700609F49Q33819493-3E4B2FA5-D413-47EA-8E14-432A6CDE4F9BQ34068037-5B66EA06-812C-41AC-8191-DD7082A8870AQ34338585-484B3784-5276-4978-9020-012F0D9A0C69Q34744920-AA8E85A4-B414-4506-9BB7-B6AECE8BF20EQ34781698-C265D9A9-8858-479F-AEE5-7BDC97AD40ACQ35198510-7D5CD30C-3AF1-490C-8ACE-934CD6F84D69Q35745815-2F68F391-DD5C-4C36-BD2B-B211F14B9AB7Q35830898-FEF85EB6-AB41-4242-B244-95A2C6EA17A6Q35859503-37F20448-4AAC-4B17-9B7E-1C869BE4B125Q35859611-E6D2CCCC-62B4-45B4-93AC-320902CAC277Q35865879-92C5DBE8-F532-49BC-B5A4-97A29F0709BEQ35869312-7C6640B9-7BA0-4D9A-A7EE-5B4B50067E0DQ35873645-BB5DB5C8-3DC0-426D-A416-A6329A3D154EQ35877383-77E8C092-A796-42BE-8770-F404C3C4E09BQ35891833-25F16872-3F91-4D7A-B0EA-60570016E0BDQ36297936-41721A93-211E-4BA9-B179-D6568E508CC1Q36464264-873BAB60-1DD0-418E-8BC1-EDED5B417C46Q36624411-210ADA24-9022-49E6-9ADF-BB57317522EEQ36638060-E1A29820-535A-4B56-BBDA-806BF5A20C47Q36639439-D7160EA0-033C-4C87-839A-87992C9D7596Q36654963-C8056730-7CA0-4AE0-8E81-FFEDA25FF9ADQ36655127-B31AA8C7-C58F-453F-BC68-F9B6D28BB35BQ36698665-C70E598F-9644-445B-A45B-A3FB8A546D80Q36700852-BEEE7912-1EA3-4F6D-9817-3CD5D8218670Q36807189-D1158728-879C-46EC-8F1C-34D7B8E5A56BQ36942505-125BAD3C-C4FA-4497-8CCF-F152EEC325A2Q37189392-6B75BE7B-C408-49F3-9C1B-D84186EAABABQ37505667-03980DFF-BE85-4DB9-863C-960DD6F62648
P2860
Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Human immunodeficiency virus-l ...... cinia virus expression system.
@en
type
label
Human immunodeficiency virus-l ...... cinia virus expression system.
@en
prefLabel
Human immunodeficiency virus-l ...... cinia virus expression system.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus-l ...... cinia virus expression system.
@en
P2093
P2860
P304
P407
P577
1990-06-01T00:00:00Z